BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4985501)

  • 1. [Candida in feces following oral administration of premixed tetracycline and amphotericin B preparation].
    Fukaya K; Kitamoto O
    Kansenshogaku Zasshi; 1970 Jan; 43(10):283-8. PubMed ID: 4985501
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effects of the administration of tetracycline-amphotericin B (Amphocycline) capsules on the growth of Candida in the feces].
    Watanabe K; Ikemoto H
    Jpn J Antibiot; 1969 Apr; 22(2):155-8. PubMed ID: 5306451
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of amphotericin B on Candida infection of the oral cavity and the intestines during tetracycline therapy].
    Chüden H; Haralambie E; Linzenmeier G
    Mykosen; 1970 Jan; 13(1):13-7. PubMed ID: 5480479
    [No Abstract]   [Full Text] [Related]  

  • 4. [Supplemental studies on amphotericin B].
    Fukaya K
    Jpn J Antibiot; 1972 Feb; 25(1):17-20. PubMed ID: 4537361
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of Amphocycline on fungal growth in the intestine].
    Yamada R; Ishio N; Takegawa S; Yamamoto I; Fujimori I
    Kansenshogaku Zasshi; 1970 Apr; 44(1):22-7. PubMed ID: 4987132
    [No Abstract]   [Full Text] [Related]  

  • 6. [Incidence of Candida albicans in infant oral materials and feces, and the sensitivity of amphotericin B to them].
    Hashimoto Y; Okuda K; Kametani H; Okumura S; Yonezawa W
    Shikwa Gakuho; 1972 Mar; 72(3):762-6. PubMed ID: 4556676
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of amphotericin B on the fungal flora in feces.
    Bodey GP
    Clin Pharmacol Ther; 1969; 10(5):675-80. PubMed ID: 5817629
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged oral treatment of chronic mucocutaneous candidiasis with Amphotericin B.
    Montes LF; Cooper MD; Bradford LG; Lauderdale RO; Taylor CD
    Arch Dermatol; 1971 Jul; 104(1):45-56. PubMed ID: 5120161
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and experimental results in colpitis therapy using Mysteclin].
    Lohmeyer H; Kröger E
    Med Klin; 1971 Sep; 66(38):1278-80. PubMed ID: 5110345
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro susceptibility and resistance of Candida spp. to hamycin.
    Athar MA
    Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of digestive candidoses by oral administration of amphotericin B].
    Reysseguier JC; Bernades P; Bonfils S
    Therapie; 1970; 25(4):723-32. PubMed ID: 5458917
    [No Abstract]   [Full Text] [Related]  

  • 12. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin.
    Ellepola AN
    Med Princ Pract; 2012; 21(5):442-6. PubMed ID: 22678101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sensitivity of fungi in the genus Candida to antimicrobial preparations].
    Paliĭ GK; Ivanova SA
    Antibiot Med Biotekhnol; 1986 Mar; 31(3):218-20. PubMed ID: 2940962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal (Candida albicans) growth after tetracycline therapy and its management.
    Mistry CJ; Apte VJ
    J Assoc Physicians India; 1971 Jun; 19(6):465-8. PubMed ID: 4938730
    [No Abstract]   [Full Text] [Related]  

  • 15. Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various doses.
    Hofstra W; de Vries-Hospers HG; van der Waaij D
    Infection; 1982; 10(4):223-7. PubMed ID: 7129644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speciation and amphotericin B sensitivity studies on blood isolates of Candida from burned patients.
    Stieritz DD; Law EJ; Holder IA
    J Clin Pathol; 1973 Jun; 26(6):405-8. PubMed ID: 4578160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-antifungal effect and adhesion to buccal epithelial cells of oral Candida dubliniensis isolates subsequent to limited exposure to amphotericin B, ketoconazole and fluconazole.
    Ellepola AN; Chandy R; Khan ZU
    J Investig Clin Dent; 2015 Aug; 6(3):186-92. PubMed ID: 24850753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Minimum inhibitory concentration of amphotericin B in yeasts of medical interest].
    Fernández Andreu CM; González Miranda M; Illnait Zaragozí MT; Martínez Machín G
    Rev Cubana Med Trop; 1998; 50(1):48-53. PubMed ID: 9842268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EUCAST technical note on Amphotericin B.
    Lass-Flörl C; Arendrup MC; Rodriguez-Tudela JL; Cuenca-Estrella M; Donnelly P; Hope W;
    Clin Microbiol Infect; 2011 Dec; 17(12):E27-9. PubMed ID: 22011310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of infections of the primary female genital tract in obstetrical and gynecological pathology. The combination of tetracycline and amphotericin B in a new preparation in topical vaginal therapy].
    Patrono D; Antonini B; Santoro A; Ceccarini M
    Minerva Ginecol; 1981 Jan; 33(1):31-48. PubMed ID: 7243062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.